Recently, it was reported that kurarinone activated Nrf2 by downregulation of the expression of KEAP1, leading to the expression of antioxidant enzymes, including HO-1 in human prostate cancer cells [39]. This evidence concerns the gene HMOX1 and prostate cancer.